Gyorgy Trencsenyi

Nagyerdei St. 98
Debrecen, HB 4032, Hungary

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 92 publications

Evaluating the cardiometabolic impact of Janus-kinase inhibition: An experimental analysis of Tofacitinib's therapeutic potential in a rodent model.

Evaluating the cardiometabolic impact of Janus-kinase inhibition: An experimental analysis of Tofacitinib's therapeutic potential in a rodent model.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: March 23, 2026

Enhanced Tumor-to-Background Contrast with [52Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer.

Enhanced Tumor-to-Background Contrast with [52Mn]Mn-BPPA-Bevacizumab VEGF-Targeted Immuno-PET in Cervical Cancer.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: February 16, 2026

Multimodal preclinical study of long-term effects of prenatal ultrasound on the mouse central nervous system.

Multimodal preclinical study of long-term effects of prenatal ultrasound on the mouse central nervous system.

Journal: Scientific reports

Published: September 19, 2025

Sc(III) Complexes of Pyclen Derivative Ligands as Probes for Hypoxia: Synthesis, Chemical Characterization, 44Sc-Radiolabeling, and Preclinical Assessment.

Sc(III) Complexes of Pyclen Derivative Ligands as Probes for Hypoxia: Synthesis, Chemical Characterization, 44Sc-Radiolabeling, and Preclinical Assessment.

Journal: Chemistry (Weinheim an der Bergstrasse, Germany)

Published: September 07, 2025

Liquid chromatographic determination of enantiomeric purity of [11C]methyl-L-methionine and O-(2-[18F]fluoroethyl)-L-tyrosine by pre-column derivatization with o-phthaldialdehyde and N-isobutyryl-L-cysteine.

Liquid chromatographic determination of enantiomeric purity of [11C]methyl-L-methionine and O-(2-[18F]fluoroethyl)-L-tyrosine by pre-column derivatization with o-phthaldialdehyde and N-isobutyryl-L-cysteine.

Journal: EJNMMI radiopharmacy and chemistry

Published: September 05, 2025

Preclinical evaluation of Manganese-52 labelled cyclodextrin: a prostaglandin E2 affine imaging probe.

Preclinical evaluation of Manganese-52 labelled cyclodextrin: a prostaglandin E2 affine imaging probe.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: July 03, 2025

Radiolabelled Cyclodextrins for the Positron Emission Tomography Imaging of Breast Cancer: Preclinical Perspectives.

Radiolabelled Cyclodextrins for the Positron Emission Tomography Imaging of Breast Cancer: Preclinical Perspectives.

Journal: Clinical and translational science

Published: April 29, 2025

Tilorone attenuates high-fat diet-induced hepatic steatosis by enhancing BMP9-Smad1/5/8 signaling.

Tilorone attenuates high-fat diet-induced hepatic steatosis by enhancing BMP9-Smad1/5/8 signaling.

Journal: GeroScience

Published: February 01, 2025

Metastasis and angiogenesis: preclinical PET study on hepatocellular carcinoma (He/De) tumor models.

Metastasis and angiogenesis: preclinical PET study on hepatocellular carcinoma (He/De) tumor models.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: January 06, 2025

In vivo Evaluation of Copper-61-Labeled Prostate-specific Membrane Antigen Targeting Novel Radiopharmaceutical: First Steps toward Clinical Implementation.

In vivo Evaluation of Copper-61-Labeled Prostate-specific Membrane Antigen Targeting Novel Radiopharmaceutical: First Steps toward Clinical Implementation.

Journal: ACS pharmacology & translational science

Published: November 26, 2024

HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab.

HER2 expression in different cell lines at different inoculation sites assessed by [52Mn]Mn-DOTAGA(anhydride)-trastuzumab.

Journal: Pathology oncology research : POR

Published: October 13, 2024

The Relationship of Metabolic Activity and αvβ3 Receptor Expression in Aggressive Breast Cancer Subtypes Tumors: A Preliminary Report.

The Relationship of Metabolic Activity and αvβ3 Receptor Expression in Aggressive Breast Cancer Subtypes Tumors: A Preliminary Report.

Journal: In vivo (Athens, Greece)

Published: September 21, 2024

Showing 1-12 of 92

Last Updated: 09/26/2026